7th edition of the IMCID

7th edition of the IMCID, the International Multidisciplinary Congress on Iron Deficiency

PharmaNutra and Zambon present the 7th edition of the IMCID, which will open this Friday in Rome, at the NH Collection Hotel Vittorio Veneto.


On Friday 8 and Saturday 9 March, PharmaNutra will be actively engaged in Rome for the 7th edition of the IMCID, the international congress dedicated to iron deficiency. The event, organised in partnership with Zambon, PharmaNutra’s trading partner for the Iberian Peninsula markets, will present new scientific results and insights regarding iron deficiency. The aim of the IMCID is to make iron supplements more effective and tolerable in various clinical settings. The focuses of the multidisciplinary congress specifically concern the following medical sectors: paediatrics and neonatology, obstetrics, gynaecology, gastroenterology, nephrology, oncology, internal medicine and PBM (patient blood management).


Iron deficiency is the leading cause of anaemia and the main problem of iron supplementation is associated with toxicity of the mineral, which makes it difficult to absorb by the body and poorly tolerated by the bowel. This often therefore leads to patients abandoning treatment or, in more severe cases, the use of risky intravenous supplementation. Thus, over time, the need to find a solution to make iron more tolerable has become more urgent.

In this context, the scientific research carried out by PharmaNutra has led to the development of Sucrosomial Technology®, an innovative patent that, through a system of protective membranes, enables iron to be released directly into the bloodstream, thus protecting the body from coming into direct contact with the mineral. SiderAL® line products are the result of this research. The line comprises Sucrosomial Iron®-based supplements, which are better tolerated and have a high level of absorption, as proven by numerous scientific studies published in recent years.

The 7th edition of the IMCID is therefore the ideal setting for presenting the most recent data obtained from clinical studies on the use of Sucrosomial Iron® in cases of severe iron deficiency. The event will be attended by doctors and researchers from all over the world, with a total of 400 expected guests, 18 posters presented and 25 speakers.